How can IBM Study Advance help clinical development?
Patient recruitment challenges and protocol amendments can lead to clinical trial delays and failures. These issues can often be traced back to the protocol design stage. Poorly conceived protocols can create problems at the study level, the program level and across the full development and commercialization lifecycle.
IBM Study Advance is built to modernize clinical trial protocol development by providing the power of data insights to facilitate informed decisions and a collaboration platform to improve efficiency. IBM Study Advance helps you create quality study protocols that facilitate an effective and efficient clinical trial.